Differential effects of antidepressant treatment on brain monoaminergic receptors.

[1]  S. Snyder,et al.  Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine. , 1979, Molecular pharmacology.

[2]  D. A. Bergstrom,et al.  Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. , 1979, The Journal of pharmacology and experimental therapeutics.

[3]  G. Aghajanian,et al.  Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. , 1978, Science.

[4]  A. Wirz-Justice,et al.  Is it possible to modify serotonin receptor sensitivity? , 1978, Life sciences.

[5]  S. Clements-Jewery.  The development of cortical β-adrenoceptor subsensitivity in the rat by chronic treatment with trazodone, doxepin and mianserine , 1978, Neuropharmacology.

[6]  D. Wong,et al.  Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin-comparison of fluoxetine and chlorimipramine. , 1978, Biochemical pharmacology.

[7]  S. Snyder,et al.  Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain. , 1978, Science.

[8]  F. Sulser.  Functional Aspects of the Norepinephrine Receptor Coupled Adenylate Cyclase System in the Limbic Forebrain and its Modification by Drugs which Precipitate or Alleviate Depression: Molecular Approaches to an Understanding of Affective Disorders , 1978, Pharmakopsychiatrie, Neuro-Psychopharmakologie.

[9]  L. S. Kung,et al.  Development of β-adrenergic receptor subsensitivity by antidepressants , 1977, Nature.

[10]  S. Snyder,et al.  Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. , 1977, Molecular pharmacology.

[11]  S. Snyder,et al.  Antidepressants and the muscarinic acetylcholine receptor. , 1977, Archives of general psychiatry.

[12]  S. Snyder,et al.  Beta adrenergic receptor binding in membrane preparations from mammalian brain. , 1976, Molecular pharmacology.

[13]  J. Schultz.  Psychoactive drug effects on a system which generates cyclic AMP in brain , 1976, Nature.

[14]  S. Snyder,et al.  Stereospecific binding ofd-lysergic acid diethylamide (LSD) to brain membranes: Relationship to serotonin receptors , 1975, Brain Research.

[15]  D. Wong,et al.  dl-N-methyl-3-(o-methoxyphenoxy)-3-phenylpropylamine hydrochloride, Lilly 94939, a potent inhibitor for uptake of norepinephrine into rat brain synaptosomes and heart. , 1975, Life sciences.

[16]  J. Mendels,et al.  The effect of tri-iodothyronine in combination with impramine on [3H]-cyclic AMP production in slices of rat cerebral cortex. , 1974, Neuropharmacology.

[17]  D. Wong,et al.  A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. , 1974, Life sciences.

[18]  S. Snyder,et al.  Muscarinic cholinergic receptor binding: regional distribution in monkey brain , 1974 .

[19]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[20]  P. A. Zwieten.  Inhibition of the Central Hypotensive Effect of Clonidine by Trazodone, a Novel Antidepressant , 1977 .